NSE: UNICHEMLAB | BSE: 506690

Expensive Performer

Download real time

697.85 -6.10 (-0.87%)

25.60% Fall from 52W High

7,618 NSE+BSE Volume

NSE 25 Mar, 2025 11:47 AM (IST)

4,913.3

Market Cap

Above industry Median

0.6

Beta 1Year

Very Low volatility

Unichem Laboratories Ltd. share price target and research reports

Name: Latest research reports of Unichem Laboratories Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Unichem Laboratories Ltd.
Rating: 5
Author: ICICI Securities Limited

Latest analyst research reports with target prices and PDF download for UNICHEMLAB, BSE:506690 Unichem Laboratories Ltd.

Unichem Laboratories Ltd.

24 May 2016, 12:00AM

697.85

-0.87%

Unichem Laboratories

Buy: Unichem Laboratories Ltd.

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Revenues grew 17.8% YoY to | 301.5 crore (I-direct estimate: | 311.1 crore) on account of 17.1% YoY growth in domestic sales to | 171.3...

Unichem Laboratories Ltd. is trading above its 200 day SMA of 671.1

Unichem Laboratories Ltd.

22 Feb 2016

697.85

-0.87%

Unichem Labs: Management Interaction: US business to gain traction (Feb 22, 2016)

Buy: Unichem Laboratories Ltd.

Target

Karvy

Unichem has completed 6 years in US market. The company started launching few products in 2009. The year 2014-2015 (USD 24 mn) saw a near 100% growth on the back new launches.

Unichem Laboratories Ltd. is trading below its 100 day SMA of 742.8

Unichem Laboratories Ltd.

27 Jan 2016

697.85

-0.87%

Unichem Laboratories

Buy: Unichem Laboratories Ltd.

ICICI Securities Limited

Unichem Laboratories Ltd. is trading below its 100 day SMA of 742.8

Unichem Laboratories Ltd.

27 Jan 2016

697.85

-0.87%

Unichem Labs: Q3FY16 Result Review Progress Continues (Jan 27, 2016)

Buy: Unichem Laboratories Ltd.

Recommendation Target

Karvy

Unichem's total revenues increased by 15.2% YoY to Rs 3.06 bn in Q3FY16 higher than our estimates of Rs 2.98 bn while on QoQ basis it increased marginally by 0.2%. Operating margins increased by 790bps YoY to 11.1% (lower than our estimate of 12.3%).

Unichem Laboratories Ltd. is trading above its 200 day SMA of 671.1

Unichem Laboratories Ltd.

19 Oct 2015

697.85

-0.87%

Unichem Labs - 2QFY16 Result Update

Buy: Unichem Laboratories Ltd.

Reliance Securities

Tepid quarter; Expect better traction in 2HFY16E Unichem's 2QFY16 result is a dampener as it continues to overcome the growth challenges in export formulations (up 14.5% yoy). It missed our numbers by 7%/29%/39% for sales, margins and APAT, respectively. While the sustained growth in India formulations (up 13.2% yoy) is a relief, operating performance (at 10.7% - down 30 bps yoy and 190bps qoq) succumbed due to poor product mix. Traction in the US business (up 43% yoy in 1HFY16) partially offset the losses in the UK subsidiary. We assess that ramp up in the US will boost export growth, while...

Unichem Laboratories Ltd. has gained 10.06% in the last 1 Week

Unichem Laboratories Ltd.

14 Jul 2015

697.85

-0.87%

Unichem Labs: Q1FY16 Result Review-Margins Outperform (Jul 14, 2015)

Hold: Unichem Laboratories Ltd.

Karvy

Unichem's total revenues increased by 6.2% YoY to Rs 3.09 bn in Q1FY16 lower than our estimates of Rs 3.16 bn. Operating margins declined by 120bps to 13.8% (higher than our estimate of 11.7%). Better gross margins and lower other expenses contributed to better operating margins. Net Profit de-grew by 4.7% YoY to Rs 288 mn as against our estimates of Rs 244 mn.

Unichem Laboratories Ltd. has gained 40.13% in the last 1 Year

No results found

Is Unichem Laboratories Ltd. worth buying?

100 Votes:

Buy 80.0%

Sell 9.0%

Hold 11.0%